Your session is about to expire
← Back to Search
TTFields + Chemotherapy for Pancreatic Cancer
Study Summary
This trial is testing a new cancer treatment that uses electric fields to kill tumor cells. The treatment is given with gemcitabine and nab-paclitaxel, and is being tested to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 256 Patients • NCT01005680Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have received treatment to ease symptoms caused by my tumor.I am 18 years old or older.My tumor is touching the first branch of the jejunal artery.I can take care of myself and am up and about more than half of the day.I have needed cancer treatment in the last 5 years, not including certain cancers.I do not have serious health issues unrelated to my cancer that would prevent me from safely participating.I am assigned to receive gemcitabine and nab-paclitaxel therapy.My condition cannot be treated with surgery and is in an advanced local stage.I have been diagnosed with a new case of pancreatic cancer.You are expected to live for at least three more months.
- Group 1: NovoTTF-200T
- Group 2: Best Standard of Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what purpose is NovoTTF-100L(P) most often employed?
"NovoTTF-100L(P) is a medical device that has shown efficacy in treating neoplasm metastasis, as well as other diseases like locally advanced non-small cell lung cancer, and metastatic bladder cancer."
Are there any other ongoing NovoTTF-100L(P) research projects?
"There are 1164 clinical trials currently underway that involve NovoTTF-100L(P), 329 of which are Phase 3 trials. These international studies are being conducted in 59487 different locations, with a significant concentration in Shanghai, China."
In how many different locations can I find this study?
"With 52 total locations, this trial is seeking patients at University of Kansas Medical Cancer Center in Fairway, Kansas, University of Maryland Comprehensive Cancer Center in Baltimore, Maryland, and Baylor Scott and White Medical Center in Temple, Texas."
Who else is applying?
How old are they?
What portion of applicants met pre-screening criteria?
What state do they live in?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger